Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) [2013] FCA 1425

FEDERAL COURT OF AUSTRALIA

Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) [2013] FCA 1425 Citation: Apotex Pty Limited v Sanofi (formerly Sanofi-Aventis) [2013] FCA 1425

Parties: APOTEX PTY LIMITED (ACN 096 916 148), APOTEX INC and APOTEX RESEARCH PRIVATE LIMITED v SANOFI (FORMERLY SANOFI-AVENTIS), SANOFI-AVENTIS US LLC and BRISTOL-MYERS SQUIBB INVESTCO LLC; SANOFI (FORMERLY SANOFI-AVENTIS), SANOFI-AVENTIS US LLC and BRISTOL-MYERS SQUIBB INVESTCO LLC v APOTEX PTY LIMITED (ACN 096 916 148)

File number: NSD 1639 of 2007

Judge: NICHOLAS J

Date of judgment: 26 November 2013

Catchwords: PRACTICE AND PROCEDURE – Whether respondents should be given leave to file amended points of defence – whether proposed amendments should be refused on the basis that respondents are seeking to approbate and reprobate – whether proposed amendments adequately pleaded and particularised

Legislation: National Health Act 1953 (Cth) ss 85(2), 99ACH, 99AEB, 99AEG

Cases cited: Acohs Pty Ltd v Ucorp Pty Ltd (2012) 201 FCR 173 Apotex Pty Ltd (formerly GenRx Pty Ltd) v Sanofi-Aventis (2008) 78 IPR 485 Apotex Pty Ltd v Sanofi-Aventis (2009) 82 IPR 416 Associated Provincial Picture Houses Ltd v Wednesbury Corporation [1948] 1 KB 223 Commonwealth v Verwayen (1990) 170 CLR 394 Express Newspapers PLC v News (UK) Ltd (1990) 18 IPR 201 GenRx Pty Ltd v Sanofi-Aventis (2007) 73 IPR 502 Les Laboratoires Servier v Apotex Inc [2011] RPC 20; [2011] EWHC 730 (Pat) Les Laboratoires Servier v Apotex Inc [2013] RPC 21; [2012] EWCA Civ 593 Lilly Icos LLC v 8PM Chemists Ltd [2010] FSR 4; [2009] EWHC 1905 Mandurah Enterprises Pty Ltd v Western Australian Planning Commission (2008) 38 WAR 276